Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neckHERBST, Roy S; ARQUETTE, Matthew; SHIN, Dong M et al.Journal of clinical oncology. 2005, Vol 23, Num 24, pp 5578-5587, issn 0732-183X, 10 p.Article

HER2 expression in salivary gland carcinomas: Dependence on histological subtypeGLISSON, Bonnie; COLEVAS, A. Dimitrios; AMREIN, Philip C et al.Clinical cancer research. 2004, Vol 10, Num 3, pp 944-946, issn 1078-0432, 3 p.Article

Esthesioneuroblastoma : The impact of treatment modalityCHAO, K. S; KAPLAN, Carol; SIMPSON, Joseph R et al.Head & neck. 2001, Vol 23, Num 9, pp 749-757, issn 1043-3074Article

A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancerGOVINDAN, Ramaswamy; LIM, Wan-Teck; ARQUETTE, Matthew A et al.Oncology reports. 2006, Vol 15, Num 1, pp 123-127, issn 1021-335X, 5 p.Article

Phase I dose and sequencing study of pegylated liposomal doxorubicin and docetaxel in patients with advanced malignanciesFRACASSO, Paula M; RODRIGUEZ, Luis C; HERZOG, Thomas J et al.Cancer. 2003, Vol 98, Num 3, pp 610-617, issn 0008-543X, 8 p.Article

Fluoxetine versus placebo in advanced cancer outpatients: A double-blinded trial of the Hoosier Oncology GroupFISCH, Michael J; LOEHRER, Patrick J; KRISTELLER, Jean et al.Journal of clinical oncology. 2003, Vol 21, Num 10, pp 1937-1943, issn 0732-183X, 7 p.Article

Phase i study of Docetaxel in combination with the p-glycoprotein inhibitor, zosuquidar, in resistant malignanciesFRACASSE, Paula M; GOLDSTEIN, Lori J; BURGESS, Michael F et al.Clinical cancer research. 2004, Vol 10, Num 21, pp 7220-7228, issn 1078-0432, 9 p.Article

A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignanciesFRACASSO, Paula M; WILLIAMS, Kerry J; RADER, Janet S et al.Cancer chemotherapy and pharmacology. 2011, Vol 67, Num 6, pp 1225-1237, issn 0344-5704, 13 p.Article